Trials / Conditions / Vaginosis, Bacterial

Vaginosis, Bacterial

24 registered clinical trials studyying Vaginosis, Bacterial — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota NCT07199998	Centre National de la Recherche Scientifique, France	—
Not Yet Recruiting	Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis NCT07527572	Kaneka Americas Holding Inc.	Phase 2 / Phase 3
Completed	Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Cond NCT04989543	Larena SAS	N/A
Completed	EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS NCT05649735	Ospedale del Mare	N/A
Terminated	Postmenopausal Pessary Users: Estrogen Versus Trimosan NCT03943823	The University of Texas Health Science Center, Houston	Phase 4
Unknown	Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial NCT03500107	Centro de Atenção ao Assoalho Pélvico	N/A
Completed	Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment NCT04171947	Value Outcomes Ltd.	N/A
Completed	Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections NCT02860845	Laboratorios Ordesa	Phase 4
Completed	Validity of Patient-Collected Wet Mounts NCT02641717	The University of Texas Health Science Center at San Antonio	N/A
Unknown	Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method NCT02558179	American International Biotechnology	—
Completed	Safety and Tolerability of Metronidazole Gel 1.3% NCT02392026	Insud Pharma	Phase 4
Completed	Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis NCT02314429	University Ghent	Phase 1
Completed	Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women NCT02272231	University of Alabama at Birmingham	—
Completed	Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis NCT02687789	Dr. August Wolff GmbH & Co. KG Arzneimittel	N/A
Completed	Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Interventio NCT03134924	University of Miami	N/A
Completed	Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14 NCT02139839	Kimberly-Clark Corporation	EARLY_Phase 1
Unknown	Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Bi NCT01448291	Eastern Virginia Medical School	Phase 4
Terminated	Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population NCT01322971	Stanford University	N/A
Unknown	Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery NCT00491270	Western Galilee Hospital-Nahariya	Phase 3
Terminated	Colposeptine for the Treatment of Bacterial Vaginosis NCT01153958	Merck KGaA, Darmstadt, Germany	Phase 4
Completed	A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetrac NCT01293643	Merck Sharp & Dohme LLC	Phase 3
Completed	Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis NCT01055106	Graceway Pharmaceuticals, LLC	Phase 2
Completed	Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman NCT00484653	Assistance Publique Hopitaux De Marseille	N/A
Completed	Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy NCT00153517	Centers for Disease Control and Prevention	Phase 2